Brief: BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases
22/08/2024 13:42
Aug 22 (Reuters) - Biovaxys Technology Corp BIOV.CD :
* BIOVAXYS DPX-BASED VACCINES EXHIBIT ROBUST EFFICACY ACROSS
MULTIPLE INFECTIOUS DISEASES
* BIOVAXYS TECHNOLOGY CORP -EXPLORING OPPORTUNITIES TO
OUT-LICENSE
DPX-RSV PRODUCT TO POTENTIAL PARTNERS
Source text for Eikon: ID:nCNWyQSs8a
Further company coverage: BIOV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biovaxys Technology
See all newsBrief: Biovaxys Appoints Former Sanofi Vaccines Executive To Board Of Directors
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000